Neuroendocrine Carcinoma of the Thymus

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-04-02
Clinical Trial Update: 3-arm Trial to Evaluate Pasireotide LAR/Everolimus Alone/in Combination in Patients With Lung/Thymus NET - LUNA Trial [Phase 2]
Phase 2 trial evaluating Pasireotide LAR and Everolimus alone or in combination for neuroendocrine carcinoma of the lung and thymus has comp…